II National Congress of Young Researchers in Biomedicine

23rd and 24th November, Hospital Universitari i Politècnic La Fe, Valencia

Programme Poster Allocation


Dr. Mara Dierssen

Dr. Dierssen is a Spanish neurobiologist, university professor and science communicator. She graduated from medical school in the Universidad de Cantabria, where she also carried out her PhD studies on neuropharmacology. Nowadays she is a world expert in the field of mental retardation and pharmacology and she is considered one of the most world outstanding researchers in Down syndrome. During her career, she worked at the Institute of Oncology Research-IRO in Hospitalet de Llobregat, where she started her own research group. Since 2007 she holds a Senior Scientist position at the Centre for Biomedical Research on Rare Diseases-CIBERER.
Her main research goal is to understand the role of putative candidate genes for human complex genetic diseases on brain cognitive systems, mainly using genetically modified mouse models. She is past president of the International Behavioral and Neural Genetics Society and the Spanish Society of Neuroscience. Dr. Dierssen has received several recognitions for her work including the Ramón Trias Fargas, the Jaime Blanco or Sisley-Lejeune awards. She currently carries out his scientific work at the Gene Regulation Center – CRG in Barcelona and is a member of the Federation of European Neuroscience Association – FENS.

Dr. Mariano Barbacid

Dr Mariano Barbacid is a Spanish molecular biochemist, known by his discoveries in molecular biology of cancer disease. He completed his PhD studies in the Universidad Complutense de Madrid (in Madrid, Spain) and afterwards he moved to the United Sates, where he he started his own group to work on the molecular biology of human tumours at the National Cancer Institute of Maryland. Some years later he was appointed director of the Oncology department of this research center.
Among his great feats, it has to be remarked the discovery of the first human oncogene H-RAS, as well as the identification of the first mutation associated to human cancer development.
His scientific career has achieved international recognition, and has been awarded with several renowned prizes such as the Young Investigator Award of the American Association of Cancer Research (USA, 1986), the Steiner Prize (Switzerland, 1988), the Ipsen Prize (France, 1994), the Brupbaher Cancer Research Prize (Switzerland, 2005) and the Medal of Honor of the International Agency for Cancer Research (WHO) (Lyon 2007).

Dr. Samuel Sánchez Ordóñez

Institut de Bioenginyeria de Catalunya (IBEC), Barcelona

Samuel Sánchez Ordóñez recibió el premio Fundación Princesa de Girona por su trayectoria científica en el campo de la nanotecnología. Es licenciado y doctor en química por la Universitat Autònoma de Barcelona. Ha realizado numerosas estancias en el extranjero y ha sido también investigador del prestigioso Instituto Max Planck de sistemas de inteligencia, en la ciudad de Stuttgart (Alemania). Actualmente forma parte del Institut de Bioenginyeria de Catalunya (IBEC), donde desarrolla sus funciones como investigador ICREA liderando su propio grupo de investigación, llamado “Smart nano-bio-devices”

Sus investigaciones principales se han centrado en el diseño de nanorrobots autopropulsados que naveguen dentro del cuerpo humano para tareas en medicina como la dosificación precisa de fármacos. El diseño de los nanorrobots permite otro tipo de usos más allá de los médicos como, por ejemplo, la limpieza de aguas contaminadas u otras aplicaciones medioambientales.